Article
Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
Breast cancer research and treatment - 1 May 2007
Lei Haixin, Hemminki Kari, Altieri Andrea, Johansson Robert, Enquist Kerstin, Hallmans Göran, Lenner Per, Försti Asta
Abstract excerpt
The importance of matrix metalloproteinases and their inhibitors in tumor progression is well documented. We wanted to investigate if single nucleotide polymorphisms (SNPs) in the promoter regions of these genes are associated with susceptibility to or progression of breast cancer. In this, so far largest case-control study, we genotyped eight SNPs in the MMP1, MMP2, MMP3, MMP9, MMP13, RECK and TIMP3 genes in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
